Skip to main content
Log in

Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Valvular heart disease remains frequent in industrialised countries since the decrease in frequency of rheumatic heart diseases has been accompanied by an increase in degenerative valve diseases. The prevalence of valvular disease increases sharply with age, as a consequence of the predominance of degenerative valvular diseases. Aortic stenosis and mitral regurgitation are the two most frequent diseases among patients referred because of valvular disease in Europe. The burden of heart valve disease in the elderly has an important impact on patient management, given the frequency of comorbidity and the increase in the risk of interventions. The changes in demographics explain why new procedures, such as transcatheter aortic valve implantation and percutaneous mitral valve repair, are potentially attractive in patients with high risk or even contraindications for surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Soler-Soler J, Galve E (2000) Worldwide perspective of valve disease. Heart 83:721–725

    Article  PubMed  CAS  Google Scholar 

  2. Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685–694

    Article  PubMed  Google Scholar 

  3. Vahanian A, Palacios IF (2004) Percutaneous approaches to valvular disease. Circulation 109:1572–1579

    Article  PubMed  Google Scholar 

  4. Marijon E, Ou P, Celermajer DS et al (2007) Prevalence of rheumatic heart disease detected by echocardiographic screening. N Engl J Med 357:470–476

    Article  PubMed  CAS  Google Scholar 

  5. Nkomo VT, Gardin JM, Skelton TN et al (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005–1011

    Article  PubMed  Google Scholar 

  6. Iung B, Baron G, Butchart EG et al (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro heart survey on valvular heart disease. Eur Heart J 24:1231–1243

    Article  PubMed  Google Scholar 

  7. Iung B, Baron G, Tornos P et al (2007) Valvular heart disease in the community: a European experience. Curr Probl Cardiol 32:609–661

    Article  PubMed  Google Scholar 

  8. Stewart BF, Siscovick D, Lind BK et al (1997) Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. J Am Coll Cardiol 29:630–634

    Article  PubMed  CAS  Google Scholar 

  9. Lindroos M, Kupari M, Heikkilä J, Tilvis R (1993) Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 21:1220–1225

    Article  PubMed  CAS  Google Scholar 

  10. Vahanian A, Baumgartner H, Bax J et al (2007) Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 28:230–268

    PubMed  Google Scholar 

  11. Bonow RO, Carabello BA, Chatterjee K et al (2008) 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52:e1–e142

    Article  PubMed  Google Scholar 

  12. Michelena HI, Desjardins VA, Avierinos J-F et al (2008) Natural history of asymptomatic patients with normally functioning or minimally dysfunctional bicuspid aortic valve in the community. Circulation 117:2776–2784

    Article  PubMed  Google Scholar 

  13. Roberts WC, Ko JM (2005) Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 111:920–925

    Article  PubMed  Google Scholar 

  14. Singh JP, Evans JC, Levy D et al (1999) Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83:897–902

    Article  PubMed  CAS  Google Scholar 

  15. Reid CL, Anton-Culver H, Yunis C, Gardin JM (2007) Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am J Cardiol 99:830–834

    Article  PubMed  Google Scholar 

  16. Freed LA, Levy D, Levine RA et al (1999) Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 341:1–7

    Article  PubMed  CAS  Google Scholar 

  17. Desjardins VA, Enriquez-Sarano M, Tajik AJ et al (1996) Intensity of murmurs correlates with severity of valvular regurgitation. Am J Med 100:149–156

    Article  PubMed  CAS  Google Scholar 

  18. Bursi F, Enriquez-Sarano M, Nkomo VT et al (2005) Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 111:295–301

    Article  PubMed  Google Scholar 

  19. Grigioni F, Enriquez-Sarano M, Zehr KJ et al (2001) Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103:1759–1764

    PubMed  CAS  Google Scholar 

  20. The Society of Thoracic Surgeons (2010). Adult Cardiac Surgery Database,Executive Summary, 10 Years STS Report—Period Ending 12/31/2009 [online], http://www.sts.org/documents/pdf/ndb2010/1stHarvestExecutiveSummary%5B1%5D.pdf

  21. Brown JM, O’Brien SM, Wu C et al (2009) Isolated aortic valve replacement in North America comprising 108, 687 patients in 10 years: changes in risks, valve types, and outcomes in the society of thoracic surgeons national database. J Thorac Cardiovasc Surg 137:82–90

    Article  PubMed  Google Scholar 

  22. Gammie JS, Sheng S, Griffith BP et al (2009) Trends in mitral valve surgery in the United States: results from the society of thoracic surgeons adult cardiac surgery database. Ann Thorac Surg 87:1431–1437

    Article  PubMed  Google Scholar 

  23. Iung B, Cachier A, Baron G et al (2005) Decision making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26:2714–2720

    Article  PubMed  Google Scholar 

  24. Mirabel M, Iung B, Baron G, et al. (2007) What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J;(in press, published on-line 9 March 2007, doi:10.1093/eurheartj/ehm001)

  25. Bach DS, Awais M, Gurm HS, Kohnstamm S (2009) Failure of guideline adherence for intervention in patients with severe mitral regurgitation. J Am Coll Cardiol 54:860–865

    Article  PubMed  Google Scholar 

  26. Toledano K, Rudski LG, Huynh T et al (2007) Mitral regurgitation: determinants of referral for cardiac surgery by Canadian cardiologists. Can J Cardiol 23:209–214

    Article  PubMed  Google Scholar 

  27. Roques F, Nashef SA, Michel P, et al. (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15:816–822; discussion 822–813

    Google Scholar 

  28. Edwards FH, Peterson ED, Coombs LP et al (2001) Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 37:885–892

    Article  PubMed  CAS  Google Scholar 

  29. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383

    Article  PubMed  CAS  Google Scholar 

  30. Lee SJ, Lindquist K, Segal MR et al (2006) Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295:801–808

    Article  PubMed  CAS  Google Scholar 

  31. Vahanian A, Alfieri O, Al-Attar N et al (2008) Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 29:1463–1470

    Article  PubMed  Google Scholar 

  32. Rodés-Cabau J, Webb JG, Cheung A et al (2010) Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 55:1080–1090

    Article  PubMed  Google Scholar 

  33. Thomas M, Schymik G, Walther T et al (2010) Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122:62–69

    Article  PubMed  Google Scholar 

  34. Leon MB, Smith CR, Mack M et al. for the PARTNER trial investigators (2010) Transcatheter Aortic-valve implantation for Aortic Stenosis in patients who cannot undergo surgery. N Eng J Med 363:1597–1607

    Google Scholar 

  35. Himbert D, Descoutures F, Al-Attar N et al (2009) Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 54:303–311

    Article  PubMed  Google Scholar 

  36. Feldman T, Kar S, Rinaldi M, et al. for the EVEREST Investigators (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 54:686–694

    Google Scholar 

  37. Tamburino C, Ussia GP, Maisano F et al (2010) Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 31:1382–1389

    Article  PubMed  CAS  Google Scholar 

  38. Franzen O, Baldus S, Rudolph V et al (2010) Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 31:1373–1381

    Article  PubMed  Google Scholar 

  39. Vahanian A, Iung B (2010) ‘Edge to edge’ percutaneous mitral valve repair in mitral regurgitation: it can be done but should it be done? Eur Heart J 31:1301–1304

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alec Vahanian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vahanian, A., Iung, B., Himbert, D. et al. Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies. Int J Cardiovasc Imaging 27, 1115–1122 (2011). https://doi.org/10.1007/s10554-011-9804-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-011-9804-7

KeyWords

Navigation